DocGo Inc. Common Stock Morgan Stanley 24th Annual Global Healthcare Conference

Yeah, absolutely. Chris, it's great to be here with you again. I know you know our story very well. For those new to DocGo, we're a mobile health and medical transportation company. We bring care to where patients are, or we transport them to and from care. Over the last 12 months or so, we've transported about 700,000 patients. We provide services across multiple states across the U.S. and the U.K. We also have a 50-state virtual practice that does about 1 million telehealth visits a year. We also remotely monitor patients, keeping track of patients, making sure their chronic conditions are not getting worse. A lot of heart failure patients. We monitor about 55,000 patients today. We have a growing business of medical transportation and mobile health, and we're really excited about it.

Absolutely. First off, we start with the problem.

Okay. In the U.S., there's a big problem with Americans suffering from chronic conditions.

Yeah Which is talked about a lot.

There's over 160 million Americans suffering from at least one chronic condition. Many are suffering from more than one, and as a result, it's crippling the system, right? Patients are getting sicker. It's costing the system more money. As it costs the system more money, it becomes more and more strained. Our goal really is to meet patients where they are. We think if we meet patients where they are in their home, for example, one of the things that I didn't mention in that intro is we'll go and visit 150,000 patients in their home this year. So we're going to meet patients where they are. We think when you meet the customer, in our case, the patient, where they are, they're more likely to improve their health outcomes.

We can help them improve their health outcomes, and as a result, they live happier and healthier lives and cost the system less money. Again, we're really targeting patients and helping patients with chronic conditions. We're dealing with aging populations. We're dealing with clinician shortages. We're dealing with rising healthcare costs. So we've built an integrated mobile health platform, again, that brings care to where patients are, either virtually through our virtual healthcare practice, we remotely monitor them, or we will go and visit them in their home when it's necessary, and that's sort of the suite of mobile healthcare services that we provide. It all works with our proprietary tech platform.

Our tech platform is optimizing the right clinician with the right diagnostics, with the right licensure, delivering the care with the right modality, in-person or remote, all for the right patient need, and optimizing that across the system. Again, we have about 1,000 vehicles providing care in the field. We have 3,000 to 4,000 healthcare heroes, ranging from EMTs, paramedics, nurses, advanced providers, MDs. Our goal is to optimize the right clinician with the right diagnostics, with the right modality. If we can do it virtually, we want to provide care virtually. It's efficient and cost-effective. If we need to be hands-on with the patient, we can also do that as well, and that integrated mobile health platform is really what differentiates us.

Okay, I'm really glad you asked this question, Chris. I know you and I have been talking about it, and I really want to be comprehensive and give very detailed specifics. The first thing to note that while the company's been generating negative EBITDA the past several quarters, most of our business lines are actually providing a positive EBITDA contribution.

DocGo, we talked about it just now, consists of multiple service lines, and currently, only a handful of those service lines in the corporate layer are responsible for the losses of the company.

Out of projected 2026 revenue, we shared at approximately, we guided to a little over $300 million of revenue. About $240 million of that $300 million is coming from business lines that are currently, today, adjusted EBITDA positive on a contribution basis.

I wanted to share that detail. Our plan and our requirement is that every business line that we continue to operate is going to contribute positive adjusted EBITDA to the portfolio, and we're expecting that to happen by the end of the year. Any business and any service line that's not generating positive EBITDA contribution is either going to be eliminated or redesigned as we progress through the year.